The association between KRAS (KRAS Proto-Oncogene, GTPase) and Lung Cancer Susceptibility 3 is supported by expert-curated evidence, drawing on a single expert-curated source, which records pathogenic variants.
Sources1
Clinical variants1
Symptoms0
Compounds0
Trials0
Publications29
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.